Hematologically important mutations: leukocyte adhesion deficiency (first update).

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Leukocyte adhesion deficiency (LAD) is a group of primary immunodeficiencies characterized by impaired leukocyte adhesion.
• This impairment leads to recurrent severe bacterial infections, neutrophilia, and poor wound healing.
• LAD subtypes arise from distinct genetic defects affecting leukocyte trafficking and function.

Purpose of the Study:

• To elucidate the genetic basis and molecular mechanisms underlying different forms of Leukocyte Adhesion Deficiency.
• To differentiate between LAD-I, LAD-II, and LAD-III based on their genetic causes and clinical manifestations.
• To understand the role of specific genes and proteins in leukocyte adhesion and immune response.

Main Methods:

• Genetic analysis to identify mutations in genes associated with leukocyte adhesion.
• Molecular characterization of protein function in affected individuals.
• Clinical assessment of patients for characteristic symptoms like infections and umbilical cord issues.

Main Results:

• LAD-I is caused by mutations in ITGB2, affecting β(2) integrins, and presents with delayed umbilical cord separation.
• LAD-II results from SLC35C1 mutations, disrupting fucosylation and leading to absence of certain blood group antigens.
• LAD-III involves FERMT3 mutations, impairing β integrin activation and causing leukocyte and platelet dysfunction.

Conclusions:

• LAD comprises heterogeneous disorders with distinct genetic etiologies and pathophysiological mechanisms.
• Understanding these genetic defects is crucial for accurate diagnosis and potential therapeutic strategies.
• Defects in leukocyte adhesion pathways have profound impacts on immune defense and overall health.